Searched for
MAHAMAYA LIFESCIENCES LISTING PRICE
CSM Technologies shares list flat at IPO price of Rs 113 on BSE, NSEThe public issue, which was open for subscription between June 24 and June 29, was subscribed 1.37 times overall. The retail investor porti...- From deep correction to fresh peaks: 10 stocks soar from 52-week lows to new highs in just three monthsSeveral large-cap Indian companies have seen their stock prices surge from 52-week lows to highs within just three months. This impressive ...
- Are kids on sale on Vinted e-commerce site? Disturbing listings spark child trafficking fears across EuropeAlarming claims of child trafficking on Vinted, fueled by suspicious product listings with coded descriptions and high prices, have prompte...
- Advit Jewels share price slides 5% after strong 37% market debut. Should you buy, sell or hold?Advit Jewels shares made a strong stock market debut, listing at a 37% premium to the IPO price before trimming gains. While analysts remai...
- TNEA Counselling Rank List 2026 released at tneaonline.org; how to check ranks, counselling details and moreTNEA 2026 Rank list released: Tamil Nadu's engineering admissions for 2026 have seen a highly competitive year, with 53 students scoring a ...
- Waterways Leisure shares slip on debut, list at 16% discount to IPO priceAhead of the listing, the IPO is commanding a grey market premium (GMP) of -Rs 51, implying a 6.31% discount to the upper price band of Rs ...
- Advit Jewels shares list at 37% premium over IPO price on NSE, BSEAdvit Jewels shares made a blockbuster stock market debut on Wednesday, listing at up to a 36% premium over the IPO price after the issue w...
- 6 IPOs open for subscription with GMPs up to 28%. Check all detailsThe fresh offerings come amid mixed investor interest in the SME segment, although listing performance has remained muted in recent weeks, ...
- Anubhav Plast shares list flat at IPO price of Rs 80 on BSE SME platformAnubhav Plast shares debuted at their IPO price of Rs 80 on the BSE SME platform, mirroring grey market expectations. The company's Rs 80 c...
- Turtlemint Fintech shares list at 11% discount to IPO price on NSE, BSETurtlemint Fintech Solutions experienced a subdued market debut, with shares listing at a discount to their IPO price on both NSE and BSE. ...
- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
- Zydus, Sunshine to set up $20 million pharma JV in Sri LankaIndian pharmaceutical giant Zydus Lifesciences has partnered with Sri Lanka's Sunshine Healthcare Lanka to establish a new manufacturing fa...
- Avience Biomedicals shares make blockbuster debut, list at 90% premium on NSE SMEAvience Biomedicals made a spectacular debut on the NSE SME platform, with its shares rocketing 90% on listing day. The Rs 30.24 crore IPO,...
- Leapfrog Engineering shares list at 4.3% discount from IPO price on BSE SMELeapfrog Engineering Services experienced a subdued market entry, with its shares listing at a 4.3% discount to the IPO price on the BSE SM...
- Liotech Industries shares list at 20% discount from IPO price on BSE SME platformThe Rs 36.02-crore IPO received a subdued response from investors, with the issue being subscribed 1.91 times during the three-day bidding ...
- Diksha Polymers shares list at 2% premium to IPO price on BSE SME platformDiksha Polymers debuted on the BSE SME platform at a slight premium, opening at Rs 114.50 against its IPO price of Rs 112. The Rs 17.9-cror...
- Clay Craft India shares to list today. Check GMP ahead of debutThe Rs 110.11-crore NSE SME IPO was subscribed 103.06 times during the three-day bidding period, led by strong demand from non-institutiona...
- Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...
- Zydus Lifesciences shares fall 2% as firm acquires US-based Assertio Holdings for $166 millionZydus Lifesciences' shares dipped 2% after completing the $166.4 million acquisition of US-based Assertio Holdings Inc. The deal, finalized...
- Zydus Lifesciences completes acquisition of AssertioThe company has successfully completed the cash tender offer, through wholly-owned subsidiary, Zara Merger Sub Inc, for all the outstanding...
Load More
